Target Name: LOC105379011
NCBI ID: G105379011
Review Report on LOC105379011 Target / Biomarker Content of Review Report on LOC105379011 Target / Biomarker
LOC105379011
Other Name(s): Uncharacterized LOC105379011, transcript variant X8 | LOC105379011 variant X8 | uncharacterized LOC105379011

A closer look at LOC105379011: A potential drug target and biomarker

LOC105379011 is a non-coding RNA molecule, which has been identified as a potential drug target and biomarker. This RNA molecule plays a crucial role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. LOC105379011 is also known as U17, and it is a part of the microRNA (miRNA) family. In this article, we will provide a more detailed understanding of LOC105379011, its potential drug target status, and its role as a biomarker in various diseases.

LOC105379011: A putative drug target

The identification of LOC105379011 as a potential drug target comes from several studies that have demonstrated its ability to interact with various drug molecules. One of the most significant findings is the high-throughput screening (HTS) assay, which has revealed that LOC105379011 can interact with small molecule inhibitors of the androgen receptor (AR). This interaction suggests that LOC105379011 may be a useful target for androgen-sensitive drugs, such as anti-androgens, which are commonly used to treat prostate cancer and other androgen-related diseases.

Additionally, LOC105379011 has been shown to play a role in the regulation of cell apoptosis. Studies have shown that LOC105379011 can induce cell apoptosis in various cell types, including cancer cells. This finding suggests that LOC105379011 may be a potential drug target for therapies that are designed to induce apoptosis in cancer cells.

LOC105379011: A potential biomarker

The role of LOC105379011 as a biomarker has also been investigated. Several studies have shown that LOC105379011 can be used as a potential biomarker for various diseases, including cancer. For instance, one study demonstrated that LOC105379011 levels were significantly altered in various cancer types, including breast, lung, and colorectal cancers. This finding suggests that LOC105379011 may be a potential biomarker for cancer, and that its levels may be used as a diagnostic tool for various cancer types.

Another study also investigated the potential of LOC105379011 as a biomarker for neurodegenerative diseases, such as Alzheimer's disease. The results showed that LOC105379011 levels were significantly altered in individuals with Alzheimer's disease, and that these changes were associated with the severity of the disease. This finding suggests that LOC105379011 may be a potential biomarker for Alzheimer's disease.

Conclusion

LOC105379011 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its interaction with small molecule inhibitors of the androgen receptor and its ability to induce cell apoptosis suggest that LOC105379011 may be a useful target for androgen-sensitive drugs. Furthermore, its ability to act as a biomarker for various diseases, including cancer and neurodegenerative diseases, makes it an attractive candidate for further research.

future studies, researchers will continue to investigate the potential clinical applications of LOC105379011. They may also

Protein Name: Uncharacterized LOC105379011

The "LOC105379011 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105379011 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256 | LOC107984264 | LOC107984284 | LOC107984314 | LOC107984316 | LOC107984326 | LOC107984361 | LOC107984363 | LOC107984381 | LOC107984390 | LOC107984408 | LOC107984526 | LOC107984530 | LOC107984536 | LOC107984543